akelos inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 16, 2025 - 21:09 GMT

Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018

Akelos -1018 for Chronic Neuropathic Pain NEW YORK, NY, UNITED STATES, April 16, 2025 /⁨EINPresswire.com⁩/ -- Akelos Receives Australian Patent Allowance on Lead Compound, AKE-1018 Patent Covers Inventions Licensed from Weill Cornell Medicine AKE- …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on January 29, 2025 - 16:01 GMT

Akelos Inc. Receives Chinese Patent For Its Lead Compound

Akelos Inc. Receives Chinese Patent For Its lead Compound NEW YORK, NY, UNITED STATES, January 29, 2025 /⁨EINPresswire.com⁩/ -- Akelos Inc. Announces China Patent Office Allowance of Patent Claiming its Lead Compound PRESS RELEASE Jan 29, 2025 …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on January 10, 2025 - 20:35 GMT

AKELOS INC RECEIVES USPTO RENEWAL OF TRADEMARK

RENEWAL OF AKELOS REGISTRATION FOR ANOTHER 10 YEARS. SOLIDIFIES BRAND IDENTITY, ENHANCED LEGAL PROTECTION NEW YORK CITY, NEW YORK, UNITED STATES, January 10, 2025 /⁨EINPresswire.com⁩/ -- Akelos Inc. Receives USPTO Renewal of Trademark …

Distribution channels: Banking, Finance & Investment Industry, Education ...

Published on January 10, 2025 - 20:21 GMT

PATENT AND TRADEMARK OFFICE OFFICIALLY ACCEPTS RENEWAL OF REGISTRATION FOR THE AKELOS TRADEMARK

THE RENEWAL OF THE AKELOS REGISTRATION FOR ANOTHER 10 YEARS SOLIDIFIES THE ORGANIZATION'S BRAND IDENTITY, PROVIDES ENHANCED LEGAL PROTECTION. NEW YORK CITY, NEW YORK, UNITED STATES, January 10, 2025 /⁨EINPresswire.com⁩/ -- Akelos Inc. Receives USPTO …

Distribution channels: Banking, Finance & Investment Industry, Education ...

Published on October 11, 2024 - 19:25 GMT

Akelos Inc. Announces Japan Patent Office Allowance Of Patent Claiming its Lead Compound

NEW YORK, NY, UNITED STATES, October 11, 2024 /⁨EINPresswire.com⁩/ -- Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti- hyperalgesic drug to treat chronic and neuropathic pain, announces that the Japan …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 20, 2024 - 19:47 GMT

Alkylphenol Binding Site Identified in Human HCN1 Channels

In a just published study in the journal Nature, three research teams identify the binding site in human HCN1 (hHCN1) ion channel. NEW YORK, NY, USA, August 20, 2024 /⁨EINPresswire.com⁩/ -- In a just published study in the journal Nature, research teams …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on June 4, 2024 - 19:34 GMT

Scott L. Dax, MS, PhD, Research and Development Champion, Joins Scientific Advisory Board of Akelos Inc.

NEW YORK, NEW YORK, UNITED STATES, June 4, 2024 /⁨EINPresswire.com⁩/ -- Scott L. Dax, MS, PhD, Research and Development Champion, Joins Scientific Advisory Board of Akelos Inc., a Biotechnology Company Akelos Inc. Appoints Dr. Scott L. Dax to Scientific …

Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...

Published on March 22, 2024 - 17:48 GMT

DR STEVEN R FOX, AN ICON IN COSMETIC DENTISTRY INVITED AS THE DISTINGUISHED SPEAKER AT THE EURO CONGRESS

DR FOX IS INVITED TO SPEAK IN LONDON AS AN EXPERT IN DENTISTRY TO ENRICH THE PROGRAM FOR ATTENDEES. NEW YORK, NEW YORK, UNITED STATES, March 22, 2024 /⁨EINPresswire.com⁩/ -- DR FOX IS INVITED TO SPEAK IN LONDON AS AN EXPERT IN DENTISTRY TO ENRICH THE …

Distribution channels: Beauty & Hair Care, Emergency Services ...

Published on January 2, 2024 - 17:07 GMT

Dr. Steven Fox, Icon in Cosmetic Dentistry, Establishes Veneer Technique to Protect the Oral Systemic Connection

Dr Fox referred to as the" Father of Dentistry in the 21rst Century" implements a new protocol for veneer preparation. NEW YORK, NEW YORK, UNITED STATES, January 2, 2024 /⁨EINPresswire.com⁩/ -- Dr Steven R Fox, Icon in Cosmetic Dentistry, …

Distribution channels: Beauty & Hair Care, Consumer Goods ...

Published on November 1, 2023 - 12:46 GMT

Correction of Cyrus Arman Announcement

NEW YORK, NEW YORK, UNITED STATES, November 1, 2023 /⁨EINPresswire.com⁩/ -- Cyrus Arman, PhD MBA, Joins Akelos Inc., as a Consultant & Head of Business Development Akelos Inc., a biotechnology company currently developing and commercializing a novel …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on October 27, 2023 - 19:31 GMT

Cyrus Arman, PhD MBA, Joins Akelos Inc., as Head of Business Development

Cyrus Arman, PhD MBA, Joins Akelos Inc., as Head of Business Development NEW YORK, NEW YORK, UNITED STATES, October 27, 2023 /⁨EINPresswire.com⁩/ -- Cyrus Arman, PhD MBA, Joins Akelos Inc., as Head of Business Development Akelos Inc., a biotechnology …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 10, 2023 - 13:49 GMT

Akelos Publication in the British Journal of Anaesthesia

NEW YORK, NEW YORK, UNITED STATES, August 10, 2023 /⁨EINPresswire.com⁩/ -- Media contact: Weill Cornell Medicine Corinne Esposito coe4003@med.cornell.edu 646-962-9547 Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests A non- …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 14, 2023 - 22:21 GMT

Akelos Inc. Announces United States Patent and Trademark Office Allowance of Patent Claiming its Lead Compound

Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti- hyperalgesic drug to treat chronic and neuropathic pain. NEW YORK, NEW YORK, UNITED STATES, February 14, 2023 /⁨EINPresswire.com⁩/ -- Akelos Inc., a …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...